ALX Oncology Holdings Inc. (ALXO) Misses Q3 EPS by 4c

ALX Oncology Holdings Inc. (NASDAQ: ALXO) reported Q3 EPS of ($0.41), $0.04 worse than the analyst estimate of ($0.37).

For earnings history and earnings-related data on ALX Oncology Holdings Inc. (ALXO) click here.

You May Also Be Interested In

• Goldman Sachs Downgrades Societe Generale SA (GLE:FP) (SCGLY) to Neutral
• UBS Upgrades Zhejiang Leapmotor Technology (9863:HK) to Buy
• UBS Upgrades InterContinental Hotels Group (IHG:LN) (IHG) to Buy